论文信息 - A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study. - 字舞流文

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study.

M. Lederman | L. Montaner | S. Ellenberg | L. Azzoni | I. Sanne | B. Rodriguez | I. Sereti | M. Rassool | J. Sierra-Madero | J. Mosqueda-Gómez | A. Piñeirúa-Menéndez | Pablo F Belaunzarán-Zamudio | J. Andrade-Villanueva | A. Tierney | A. López-Martínez | César Rivera Benítez